Skip to main content
. 2020 Jun 12;18:345–353. doi: 10.1016/j.omtm.2020.06.007

Figure 5.

Figure 5

Study Schedule

Animals in groups 1a, b, c, d, e, and f were dosed with aflibercept, 1.2 mg/eye. Animals in groups 2, 3, and 4 were dosed with ADVM-022 OU at 2 × 1011, 6 × 1011, and 2 × 1012 vg/eye, respectively. On day 1, CFP, FA, and OCT data were collected only for group 1a, prior to termination.